• Open Access

Management of hepatocellular carcinoma: An update


  • Jordi Bruix,

    Corresponding author
    1. Barcelona Clinic Liver Cancer (BCLC) Group, Liver Unit, Hospital Clínic, University of Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain
    • Hospital Clinic, University of Barcelona, IDIPAPS, CIBERehd, c/Villarroel 170, Barcelona 08036, Catalonia, Spain
    Search for more papers by this author
    • fax: (34) 93-227-9803

  • Morris Sherman

    1. University of Toronto and University Health Network, Toronto, Canada
    Search for more papers by this author

  • Potential conflict of interest: Dr. Bruix advises, consults for, serves on the speaker's bureau of, and received grants from Bayer. Dr. Bruix consults for Biocompatibles, GlaxoSmithKline, Kowa, Novartis, and Arqule. Dr. Bruix also advises and consults for Bristol-Myers Squibb. Dr. Sherman serves on the speakers' bureau of Bayer

  • Re-use of this article is permitted in accordance with the Terms and Conditions set out at

No abstract is available for this article.